EQUITY RESEARCH MEMO

NorayBio

Generated 5/11/2026

Executive Summary

Conviction (model self-assessment)60/100

NorayBio is a Spanish bioinformatics company founded in 2006 that provides IT solutions for managing scientific research data. Its flagship product, AniBio, is a comprehensive software platform designed to manage the full lifecycle of bioscience research, from data collection to analysis. The company focuses on the diagnostics and antibodies sectors, offering bioinformatic answers to scientific questions. Despite being a small private firm with no disclosed funding or valuation, NorayBio has established a niche in the European bioinformatics market. Its software ecosystem aims to streamline research workflows, improve data integrity, and accelerate discoveries. The company's long-standing presence since 2006 suggests stability and domain expertise, though its growth trajectory remains limited by its small scale and lack of notable partnerships or commercial products. With the increasing digitization of life sciences, NorayBio has opportunities to expand its customer base and enhance its platform capabilities.

Upcoming Catalysts (preview)

  • Q3 2026Launch of AniBio Next-Gen Version70% success
  • Q2 2026Strategic Partnership with European Biotech Consortium50% success
  • Q4 2026Expansion into Latin American Market40% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)